Cargando…
Xeroderma pigmentosum at a tertiary care center in Saudi Arabia
BACKGROUND: Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder caused by defective DNA repair that results in extreme sensitivity to ultraviolet (UV) rays. Depending on the type of XP, the disease may affect the skin, eyes and nervous system. OBJECTIVES: Describe the dermatologic mani...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
King Faisal Specialist Hospital and Research Centre
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150578/ https://www.ncbi.nlm.nih.gov/pubmed/28578364 http://dx.doi.org/10.5144/0256-4947.2017.240 |
_version_ | 1783357017009684480 |
---|---|
author | Alwatban, Lenah Binamer, Yousef |
author_facet | Alwatban, Lenah Binamer, Yousef |
author_sort | Alwatban, Lenah |
collection | PubMed |
description | BACKGROUND: Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder caused by defective DNA repair that results in extreme sensitivity to ultraviolet (UV) rays. Depending on the type of XP, the disease may affect the skin, eyes and nervous system. OBJECTIVES: Describe the dermatologic manifestations in patients suffering from XP. DESIGN: Retrospective, descriptive review of medical records. SETTING: Dermatology clinic at tertiary care center in Riyadh. PATIENTS AND METHODS: This study included Saudi patients with clinically confirmed XP. MAIN OUTCOME MEASURE(S): Demographic and clinical data including pathology and associated conditions and outcomes. RESULTS: Of 21 patients with XP, the most common manifestation was lentigines, affecting 18 patients (86%). The most common skin cancer was basal cell carcinoma followed by squamous cell carcinoma (SCC) affecting 15 (71.4%) and 9 (42.8%), respectively. Other skin findings included neurofibroma, trichilemmoma and seborrheic keratosis. Ocular involvement included photophobia, which was the most common finding followed by dryness and ocular malignancies. Two patients showed neurological involvement, which correlated with the type of mutation. CONCLUSION: Considering that XP is a rare genetic disease, this description of our patient population will aid in early recognition and diagnosis. LIMITATIONS: Retrospective and small number of patients. Genetic analyses were done for only 5 of the 21 patients. |
format | Online Article Text |
id | pubmed-6150578 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | King Faisal Specialist Hospital and Research Centre |
record_format | MEDLINE/PubMed |
spelling | pubmed-61505782018-09-25 Xeroderma pigmentosum at a tertiary care center in Saudi Arabia Alwatban, Lenah Binamer, Yousef Ann Saudi Med Original Article BACKGROUND: Xeroderma pigmentosum (XP) is a rare autosomal recessive disorder caused by defective DNA repair that results in extreme sensitivity to ultraviolet (UV) rays. Depending on the type of XP, the disease may affect the skin, eyes and nervous system. OBJECTIVES: Describe the dermatologic manifestations in patients suffering from XP. DESIGN: Retrospective, descriptive review of medical records. SETTING: Dermatology clinic at tertiary care center in Riyadh. PATIENTS AND METHODS: This study included Saudi patients with clinically confirmed XP. MAIN OUTCOME MEASURE(S): Demographic and clinical data including pathology and associated conditions and outcomes. RESULTS: Of 21 patients with XP, the most common manifestation was lentigines, affecting 18 patients (86%). The most common skin cancer was basal cell carcinoma followed by squamous cell carcinoma (SCC) affecting 15 (71.4%) and 9 (42.8%), respectively. Other skin findings included neurofibroma, trichilemmoma and seborrheic keratosis. Ocular involvement included photophobia, which was the most common finding followed by dryness and ocular malignancies. Two patients showed neurological involvement, which correlated with the type of mutation. CONCLUSION: Considering that XP is a rare genetic disease, this description of our patient population will aid in early recognition and diagnosis. LIMITATIONS: Retrospective and small number of patients. Genetic analyses were done for only 5 of the 21 patients. King Faisal Specialist Hospital and Research Centre 2017 /pmc/articles/PMC6150578/ /pubmed/28578364 http://dx.doi.org/10.5144/0256-4947.2017.240 Text en © 2017 Annals of Saudi Medicine This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
spellingShingle | Original Article Alwatban, Lenah Binamer, Yousef Xeroderma pigmentosum at a tertiary care center in Saudi Arabia |
title | Xeroderma pigmentosum at a tertiary care center in Saudi Arabia |
title_full | Xeroderma pigmentosum at a tertiary care center in Saudi Arabia |
title_fullStr | Xeroderma pigmentosum at a tertiary care center in Saudi Arabia |
title_full_unstemmed | Xeroderma pigmentosum at a tertiary care center in Saudi Arabia |
title_short | Xeroderma pigmentosum at a tertiary care center in Saudi Arabia |
title_sort | xeroderma pigmentosum at a tertiary care center in saudi arabia |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150578/ https://www.ncbi.nlm.nih.gov/pubmed/28578364 http://dx.doi.org/10.5144/0256-4947.2017.240 |
work_keys_str_mv | AT alwatbanlenah xerodermapigmentosumatatertiarycarecenterinsaudiarabia AT binameryousef xerodermapigmentosumatatertiarycarecenterinsaudiarabia |